(TORONTO, ON – October 9, 2019) – Astellas Pharma US announced the three finalists for its fourth annual C3 (Changing Cancer Care) Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones.
Nanny Angel Network (now Nankind) is thrilled to announce that we have been selected as one of only three finalists for this prestigious award. We are the only Canadian organization selected as a finalist to compete in the final event.
The three grand prize finalists, including NAN, will pitch their ideas to a panel of judges on October 25 during a live event in New York City. NAN’s Kingston Champion Leah Werry will travel to NYC to represent us at the C3 Prize-partner TEDMED event.
The Astellas Oncology C3 Prize launched in 2016 as a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine. Nanny Angel Network is proud to be recognized for our existing work to fill the gaps in health and social care and should we win, the Astellas C3 Prize funding will help us in our goal to lessen the impact of cancer on families across Canada and beyond.
More details on how to watch the C3 Prize TEDMED presentation will be shared as we learn them. Please visit www.c3prize.com to learn more about this award.